Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124953862 | 12495386 | 2 | F | 201507 | 20160727 | 20160624 | 20160802 | EXP | CA-AMGEN-CANSL2016079142 | AMGEN | 78.00 | YR | E | F | Y | 44.90000 | KG | 20160802 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124953862 | 12495386 | 1 | PS | PROLIA | DENOSUMAB | 1 | Subcutaneous | 60 MG/ML, Q6MO | 1063420 | 125320 | SOLUTION FOR INJECTION | ||||||||
| 124953862 | 12495386 | 2 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 20 UNK, UNK | 0 | |||||||||||
| 124953862 | 12495386 | 3 | C | RANITIDINE. | RANITIDINE | 1 | 150 MG, UNK | 0 | 150 | MG | |||||||||
| 124953862 | 12495386 | 4 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 124953862 | 12495386 | 5 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | 60 MG, UNK | 0 | 60 | MG | |||||||||
| 124953862 | 12495386 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 124953862 | 12495386 | 7 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 1000 IU, UNK | 0 | 1000 | IU | |||||||||
| 124953862 | 12495386 | 8 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 75 MG, UNK | 0 | 75 | MG | |||||||||
| 124953862 | 12495386 | 9 | C | IRON | IRON | 1 | 300 MG, UNK | 0 | 300 | MG | |||||||||
| 124953862 | 12495386 | 10 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 1200 MUG, UNK | 0 | 1200 | UG | |||||||||
| 124953862 | 12495386 | 11 | C | CALCIUM | CALCIUM | 1 | 500 UNK, UNK | 0 | |||||||||||
| 124953862 | 12495386 | 12 | C | DILTIAZEM. | DILTIAZEM | 1 | 180 MG, UNK | 0 | 180 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124953862 | 12495386 | 1 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124953862 | 12495386 | OT |
| 124953862 | 12495386 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124953862 | 12495386 | Anal incontinence | |
| 124953862 | 12495386 | Arrhythmia | |
| 124953862 | 12495386 | Atrioventricular block | |
| 124953862 | 12495386 | Cardiac operation | |
| 124953862 | 12495386 | Cerebrovascular accident | |
| 124953862 | 12495386 | Neurogenic shock | |
| 124953862 | 12495386 | Syncope | |
| 124953862 | 12495386 | Transient ischaemic attack |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124953862 | 12495386 | 1 | 20120229 | 0 |